These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28306595)

  • 1. Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
    Singer O; McCune WJ
    Curr Opin Rheumatol; 2017 May; 29(3):248-253. PubMed ID: 28306595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti B-cell-antibody treatment for maintenance of remission in granulomatosis with polyangiitis and microscopic polyangiitis].
    de Groot K; Aries PM; Haubitz M; Hellmich B; Lamprecht P; Thiel J
    Dtsch Med Wochenschr; 2020 Jan; 145(1):40-46. PubMed ID: 31914468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
    Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Ding L; Iklé D; Villareal M; Lim N; Brunetta P; Fervenza FC; Monach PA; Stone JH;
    Arthritis Rheumatol; 2015 Jun; 67(6):1629-36. PubMed ID: 25776953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis.
    Puéchal X; Pagnoux C; Perrodeau É; Hamidou M; Boffa JJ; Kyndt X; Lifermann F; Papo T; Merrien D; Smail A; Delaval P; Hanrotel-Saliou C; Imbert B; Khouatra C; Lambert M; Leské C; Ly KH; Pertuiset E; Roblot P; Ruivard M; Subra JF; Viallard JF; Terrier B; Cohen P; Mouthon L; Le Jeunne C; Ravaud P; Guillevin L;
    Arthritis Rheumatol; 2016 Mar; 68(3):690-701. PubMed ID: 26473755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE; Sanders JSF; Puéchal X; Guillevin LP; Hiemstra TF; Flossmann O; Rasmussen N; Westman K; Jayne DR; Stegeman CA
    Rheumatology (Oxford); 2017 Nov; 56(11):1894-1901. PubMed ID: 28977502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission maintenance in ANCA-associated vasculitis: does one size fit all?
    Berti A; Specks U
    Expert Rev Clin Immunol; 2019 Dec; 15(12):1273-1286. PubMed ID: 31762340
    [No Abstract]   [Full Text] [Related]  

  • 9. Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab.
    Geetha D; Kallenberg C; Stone JH; Salama AD; Appel GB; Duna G; Brunetta P; Jayne D
    J Nephrol; 2015 Feb; 28(1):17-27. PubMed ID: 25185728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
    Azar L; Springer J; Langford CA; Hoffman GS
    Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How best to manage relapse and remission in ANCA-associated vasculitis.
    Puéchal X; Guillevin L
    Expert Rev Clin Immunol; 2022 Nov; 18(11):1135-1143. PubMed ID: 36102147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
    Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
    Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
    Guillevin L; Pagnoux C; Karras A; Khouatra C; Aumaître O; Cohen P; Maurier F; Decaux O; Ninet J; Gobert P; Quémeneur T; Blanchard-Delaunay C; Godmer P; Puéchal X; Carron PL; Hatron PY; Limal N; Hamidou M; Ducret M; Daugas E; Papo T; Bonnotte B; Mahr A; Ravaud P; Mouthon L;
    N Engl J Med; 2014 Nov; 371(19):1771-80. PubMed ID: 25372085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
    Santana AN; Woronik V; Halpern AS; Barbas CS
    J Bras Pneumol; 2011; 37(6):809-16. PubMed ID: 22241040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Should Type of ANCA Guide the Treatment?
    Tesar V; Hruskova Z
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1519-1521. PubMed ID: 32471814
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
    PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
    Brogan P; Yeung RSM; Cleary G; Rangaraj S; Kasapcopur O; Hersh AO; Li S; Paripovic D; Schikler K; Zeft A; Bracaglia C; Eleftheriou D; Pordeli P; Melega S; Jamois C; Gaudreault J; Michalska M; Brunetta P; Cooper JC; Lehane PB;
    Arthritis Rheumatol; 2022 Jan; 74(1):124-133. PubMed ID: 34164952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Therapies for ANCA-associated Vasculitis.
    Monti S; Brandolino F; Milanesi A; Xoxi B; Delvino P; Montecucco C
    Curr Rheumatol Rep; 2021 Apr; 23(6):38. PubMed ID: 33909172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.